Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-07-24
2000-07-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 63, 540548, A61K 31553, C07D49802, A61P 710
Patent
active
060908033
ABSTRACT:
The present invention provides compounds of the general formula: ##STR1## wherein W is O or NH, optionally substituted, as well as methods and pharmaceutical compositions utilizing these compounds for the treatment of disorder which may be remedied or alleviated by vasopressin agonist activity, including diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, bleeding and coagulation disorders, or temporary delay of urination.
REFERENCES:
patent: 4766108 (1988-08-01), Ali
patent: 5055448 (1991-10-01), Manning et al.
patent: 5070187 (1991-12-01), Gavras et al.
patent: 5420270 (1995-05-01), Chandrakumar et al.
patent: 5512563 (1996-04-01), Albright et al.
patent: 5516774 (1996-05-01), Albright et al.
patent: 5521173 (1996-05-01), Venkatesan et al.
patent: 5536718 (1996-07-01), Albright et al.
Cervoni, P. and Chan, P.S., Diuretic Agents, in Kirk-Othmer: Encyclopedia of Chemical Technology, 4th Ed., Wiley, vol. 8, 398-432, 1993.
Jackson, E.K., Goodman's and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., Eds, Hardman, Limbird, Molinoff, Ruddon and Gilman, McGraw-Hill, New York, pp. 715-731, 1996.
Alami et al., Tetrahedron Lett., 34, 6403, (1993).
Albini, A., Synthesis, 263 (1993).
Brenes-Pereira, C., Texas Heart Institute Journal, 24 (2), 118 (1997).
Burggraaf, J. et al., Clin. Sci., 86, 497 (1994).
Cabri et al., Tetrahedron Lett., 32, 1753 (1991).
Cash, J.D. et al., Brit. J. Haematol, 27, 363 (1974).
Cecchi, L. et al., J. Het. Chem., 20, 871 (1983).
Coffen et al., J. Org. Chem., 49, 296 (1984).
Coppola et al., J. Het. Chem., 11, 51 (1974).
Craig et al., Tetrahedron Lett., No. 42, 4025 (1979).
David, J-L., Regulatory Peptides, 45, 311 (1993).
duVigneaud, V. et al., J. Am. Chem. Soc., 76, 4751 (1954).
Farina et al., J. Org. Chem., 59, 5905 (1994).
Hallstrom, et al., Tetrahedron Lett., vol. 21, 667 (1980).
Huguenin et al., Helv. Chim. Acta, 49, 695 (1966).
Inanaga et al., Bull. Chem. Soc. Jpn., 52, 1989 (1979).
Jones, R.A., Aldrichimica ACTA, 9(3), 35 (1976).
Kantlehner et al., Chem. Ber., 105, 1340 (1972).
Khuthier, A-H. et al., J. Chem. Soc. Chem. Commun., 9 (1979).
Klaubert, D.H., J. Het. Chem., 22, 333 (1985).
Knorr et al., J. Org. Chem., 49 1288 (1984).
Kosugi et al., Bull. Chem. Soc. Jpn., 60, 767 (1987).
Lethagen, S., Ann. Hematol., 69, 173 (1994).
Ligouri et al., Tetrahedron, 44, 1255 (1988).
Lin et al., J. Het. Chem., 14, 345 (1977).
Manning et al., J. Med. Chem., 35, 3895 (1992).
Manning et al., J. Med. Chem., 35, 382 (1992).
Martina et al., Synthesis, 8, 613 (1991).
Martinez et al., J. Med. Chem., 35, 620 (1992).
Mayet et al., J. of the Royal College of Physicians of London, 31 (3), 313 (1997).
Murray, R.W., Chem. Rev., 89, 1187 (1989).
Oliver et al., J. Physiol. (London), 18, 277 (1895).
Reed et al., J. Org. Chem., 52, 3491 (1987).
Ruffolo et al., Drug News and Perspective, 4(4), 217 (May 1991).
Sanogashira et al., Tetrahedron Lett., 50, 4467 (1975).
Street et al., J. Med. Chem., 36, 1529 (1993).
Williams. P.D., J. Med. Chem., 35, 3905 (1992).
Failli Amedeo A.
Shumsky Jay S.
Steffan Robert J.
American Home Products Corporation
Coleman Brenda
Eck Steven R.
Shah Mukund J.
LandOfFree
Tricyclic vasopressin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic vasopressin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic vasopressin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037312